These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 8540690)

  • 41. Drug susceptibility in emerging fungal infections: tests with fluconazole, itraconazole, and amphotericin B.
    Fay VDS; Rodrigues DMG; Gonçalves SMB; Gregianini TS; Bonamigo RR
    An Bras Dermatol; 2018 Jun; 93(3):462-464. PubMed ID: 29924220
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fungal sinusitis.
    Nichols L
    N Engl J Med; 1997 Nov; 337(22):1633-4. PubMed ID: 9411230
    [No Abstract]   [Full Text] [Related]  

  • 43. Synergistic antifungal interactions of amphotericin B with 4-(5-methyl-1,3,4-thiadiazole-2-yl) benzene-1,3-diol.
    Chudzik B; Bonio K; Dabrowski W; Pietrzak D; Niewiadomy A; Olender A; Malodobry K; Gagoś M
    Sci Rep; 2019 Sep; 9(1):12945. PubMed ID: 31506532
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Second-generation azole antifungal agents.
    Kale P; Johnson LB
    Drugs Today (Barc); 2005 Feb; 41(2):91-105. PubMed ID: 15821782
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Azole antifungal agents.
    Bodey GP
    Clin Infect Dis; 1992 Mar; 14 Suppl 1():S161-9. PubMed ID: 1314105
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A nationwide passive surveillance on fungal infections shows a low burden of azole resistance in molds and yeasts in Tyrol, Austria.
    Lass-Flörl C; Mayr A; Aigner M; Lackner M; Orth-Höller D
    Infection; 2018 Oct; 46(5):701-704. PubMed ID: 29971692
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Linkage between genes involved in azole resistance and ergosterol biosynthesis.
    Moye-Rowley WS
    PLoS Pathog; 2020 Sep; 16(9):e1008819. PubMed ID: 32881974
    [No Abstract]   [Full Text] [Related]  

  • 48. Antifungal activity of flocculosin, a novel glycolipid isolated from Pseudozyma flocculosa.
    Mimee B; Labbé C; Pelletier R; Bélanger RR
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1597-9. PubMed ID: 15793149
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antifungal drugs.
    Cross JT; Hickerson SL; Yamauchi T
    Pediatr Rev; 1995 Apr; 16(4):123-9. PubMed ID: 7731906
    [No Abstract]   [Full Text] [Related]  

  • 50. New antifungal compounds and strategies for treatment of invasive fungal infections in patients with neoplastic diseases.
    Walsh TJ; Lyman CA
    Cancer Treat Res; 1995; 79():113-48. PubMed ID: 8746652
    [No Abstract]   [Full Text] [Related]  

  • 51. Amphotericin B lipid complex for the treatment of invasive fungal infections.
    Linden PK
    Expert Opin Pharmacother; 2003 Nov; 4(11):2099-110. PubMed ID: 14596663
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Review article. Molecular basis of antimycotic therapy].
    Bastert J; Korting HC
    Mycoses; 1999; 42 Suppl 1():73-9. PubMed ID: 10592721
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The current role of amphotericin B lipid complex in managing systemic fungal infections.
    Chu P; Sadullah S
    Curr Med Res Opin; 2009 Dec; 25(12):3011-20. PubMed ID: 19849324
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antifungal therapy and the new azole compounds.
    Hay RJ
    J Antimicrob Chemother; 1991 Jul; 28 Suppl A():35-46. PubMed ID: 1938705
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pharmacokinetics and pharmacodynamics of antifungal drugs in children].
    Jullien V
    Arch Pediatr; 2011 May; 18 Suppl 1():S42-7. PubMed ID: 21596286
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The biology and chemistry of antifungal agents: a review.
    Kathiravan MK; Salake AB; Chothe AS; Dudhe PB; Watode RP; Mukta MS; Gadhwe S
    Bioorg Med Chem; 2012 Oct; 20(19):5678-98. PubMed ID: 22902032
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antifungal therapy: from amphotericin B to present.
    Dismukes WE
    Trans Am Clin Climatol Assoc; 1993; 104():166-77; discussion 177-9. PubMed ID: 1343440
    [No Abstract]   [Full Text] [Related]  

  • 58. Targeting efflux pumps to overcome antifungal drug resistance.
    Holmes AR; Cardno TS; Strouse JJ; Ivnitski-Steele I; Keniya MV; Lackovic K; Monk BC; Sklar LA; Cannon RD
    Future Med Chem; 2016 Aug; 8(12):1485-501. PubMed ID: 27463566
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synergism of amphotericin B with other antimicrobial agents.
    Smith JW
    Ann Intern Med; 1973 Mar; 78(3):450. PubMed ID: 4694899
    [No Abstract]   [Full Text] [Related]  

  • 60. Efficacy of amphotericin B and azoles alone and in combination against disseminated trichosporonosis in neutropenic mice.
    Kamberi P; Atsuro H; Takayoshi T; Masaru N
    Chemotherapy; 1998; 44(1):55-62. PubMed ID: 9444410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.